The impact of UPA on endometriosis lesions and symptoms was observed over a 27-month period leading up to surgery, with 58% of cases showing progesterone receptor modulator-associated endometrial changes (PAECs) in both eutopic endometrium and ectopic lesions, correlating with decreased pain and amenorrhea. This evidence concerns the gene PGR and endometriosis.